These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5332873)

  • 41. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
    Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
    Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.
    Derrick SC; Yang AL; Morris SL
    Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell walls.
    Reuben JM; Tanner CE; Portelance V
    Infect Immun; 1979 Mar; 23(3):582-6. PubMed ID: 378829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.
    Yamamoto K; Granger DL; Brehmer W; Azuma I; Ribi E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):127-41. PubMed ID: 6797153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
    PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization of mice by combinations of inactive fractions of Mycobacterium bovis strain BCG.
    Anacker RL; Bickel WD; Brehmer W; Niwa M; Ribi E; Tarmina DF
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):723-30. PubMed ID: 4975293
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.
    Grode L; Seiler P; Baumann S; Hess J; Brinkmann V; Nasser Eddine A; Mann P; Goosmann C; Bandermann S; Smith D; Bancroft GJ; Reyrat JM; van Soolingen D; Raupach B; Kaufmann SH
    J Clin Invest; 2005 Sep; 115(9):2472-9. PubMed ID: 16110326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    Arrieta-Villegas C; Perálvarez T; Vidal E; Puighibet Z; Moll X; Canturri A; Sevilla IA; Espada Y; Juste RA; Domingo M; Pérez de Val B
    PLoS One; 2018; 13(5):e0196948. PubMed ID: 29742150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.
    Chambers MA; Williams A; Gavier-Widén D; Whelan A; Hall G; Marsh PD; Bloom BR; Jacobs WR; Hewinson RG
    Infect Immun; 2000 Dec; 68(12):7094-9. PubMed ID: 11083835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of footpad sensitivity to purified protein derivatives and resistance to airborne infection with Mycobacterium tuberculosis of mice vaccinated with mycobacterial cell walls.
    Anacker RL; Ribi E; Tarmina DF; Fadness L; Mann RE
    J Bacteriol; 1969 Oct; 100(1):51-7. PubMed ID: 4981063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w.
    Singh IG; Mukherjee R; Talwar GP
    Vaccine; 1991 Jan; 9(1):10-4. PubMed ID: 1901186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice.
    Hetland G; Løvik M; Wiker HG
    Scand J Immunol; 1998 Jun; 47(6):548-53. PubMed ID: 9652822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals.
    Smith DW; Wiegeshaus E; Navalkar R; Grover AA
    J Bacteriol; 1966 Feb; 91(2):718-24. PubMed ID: 4956758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3.
    Kelly MT
    Infect Immun; 1977 Jan; 15(1):180-3. PubMed ID: 319056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tuberculin shock in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Oct; 84B(5):273-79. PubMed ID: 823795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
    Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
    Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.
    Hovav AH; Fishman Y; Bercovier H
    Infect Immun; 2005 Jan; 73(1):250-7. PubMed ID: 15618161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.